Journals / Gülhane Tıp Dergisi / 2013 / Cilt: 55 - Sayı: 1

MTHFR gene mutation in an elderly patient that comes with portal vein thrombosis and ascites: A case report

İleri yaşta portal ven trombozu ve assit ile gelen bir MTHFR gen mutasyonu olgusu

Pages
66–69
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we present a case of homozygous MTHFR gene mutation that comes with portal vein thrombosis, liver failure and ascites.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Extrahepatic portal vein thrombosis is a common cause of presinusoidal portal hypertension and often the two entities connote each other.
📊
Key Findings & Data:Portal vein thrombosis is reported in patients with underlying cirrhosis by 25%.
💡
Conclusion & Impact:Here, we present a case of homozygous MTHFR gene mutation that comes with portal vein thrombosis, liver failure and ascites.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Extrahepatic portal vein thrombosis is a common cause of presinusoidal portal hypertension and often the two entities connote each other. Portal vein thrombosis is reported in patients with underlying cirrhosis by 25%. Other than cirrhotic patients; malignancies, myeloproliferative disorders, collagen tissue disorders, pancreatitis, and thrombophilias can cause portal vein thrombosis. Conditions predisposing to thrombosis are mostly acquired. Hereditary disorders predisposing to thrombosis like FV Leiden mutation, prothrombin gene mutation, MTHFR gene mutation, protein C, S, and antithrombin 3 deficiency diseases are more rare. Sometimes with an accompanying factor provoking thrombosis, these abnormalities are usually under the age of 50 and present with venous thrombosis. Here, we present a case of homozygous MTHFR gene mutation that comes with portal vein thrombosis, liver failure and ascites.

Özet

Portal ven trombozu, karaciğer dışı presinüzoidal portal hipertansiyonun sık görülen bir nedenidir ve genellikle bu iki antite birbirini çağrıştırır. Portal ven trombozu olan hastalarda %25 oranında altta yatan siroz bildirilmektedir. Sirotik olgular dışında maligniteler, miyeloproliferatif hastalıklar, kollajen doku hastalıkları, pankreatit ve tromboza eğilim oluşturan durumlar da portal ven trombozu nedeni olabilmektedir. Tromboza eğilim oluşturan durumlar çoğunlukla edinseldir. Kalıtsal olarak tromboza eğilim oluşturan FV Leiden mutasyonu, protrombin gen mutasyonu, MTHFR gen mutasyonu, protein C, S ve antitrombin 3 eksikliği gibi bozukluklara daha nadir rastlanır. Bazen trombozu provoke eden bir nedenin eşlik edebildiği bu bozukluklar genellikle 50 yaş altında ve venöz trombozlar ile karşımıza çıkmaktadır. Burada ileri yaşta portal ven trombozu, buna sekonder karaciğer yetmezliği ve assit tablosu ile gelmiş homozigot MTHFR gen mutasyonu saptanan bir hastamızı sunmaktayız.

🔖

Cite This Article

ÇAKAR, M., DEMİRBAŞ, Ş., KURT, Ö., KARADURMUŞ, N. (2013). MTHFR gene mutation in an elderly patient that comes with portal vein thrombosis and ascites: A case report. Gülhane Tıp Dergisi, Cilt: 55 - Sayı: 1, 66–69. https://ajindex.com/articles/216929

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Okuda K, Ohnishi K, Kimura K, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology. 1985; 89: 279- 86
  2. Kameda H, Yamazaki K, Imai F. Obliterative portal venopathy: A comparative study of 184 cases of extrahepatic portal obstruction and 469 cases of idiopathic portal hypertension. J Gastroenterol Hepatol. 1986; 1: 139-149
  3. Webb L, Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med. 1979; 48: 627-39
  4. Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism-- results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost. 1997; 77: 444-51
  5. Crowther M, Kelton J. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med. 2003; 138: 128-34
  6. Belli L, Romani F, Riolo F, et al. Thrombosis of portal vein in absence of hepatic disease. Surg Gynecol Obstet. 1989; 169: 46-9
  7. Amitrano L, Guardascione M, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004; 40: 736-41
  8. Heijer M den, Rosendaal F, Blom H, Gerrits W, Bos G. Hyperhomocysteinemia and venous thrombosis: a meta- analysis. Thromb Haemost. 1998; 80: 874-7
  9. Ray J. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med. 1998; 158: 2101-6
  10. Heijer M, Willems H, Blom H, et al. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial. Blood. 2007; 109: 139-44.